We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Europe Making Progress on Biogenerics, But Questions Remain on Regulatory Pathway
Europe Making Progress on Biogenerics, But Questions Remain on Regulatory Pathway
May 18, 2005
Although the European Union (EU) is outpacing the U.S. in implementing an approval system for follow-on biologics, some industry observers are cautioning regulators not to move too quickly on biogenerics, saying holes remain in the regulatory process.